Briacell Therapeutics Corp BCTX

$3.27 +0.08 (2.51%)

Valuation

Market cap
27,856,000
Revenue TTM
$0
Net income TTM
$-26,310,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
94,800
Avg volume
112,830
Day's range
$3.06 – $3.41
Shares out
8,732,000
Stochastic %K
44%
Beta
1.26
Analysts
—
Price target
$40.00

Price

Company profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...

Show more

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 921 1810
Website
https://briacell.com
Address
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

Latest news

Stocktwits

smallpower17 Nov 5, 10:01 PM
$BCTX Up 2.5% today is a very bullish signal. Great things headed our way and soon.
0 replies
smallpower17 Nov 5, 6:06 PM
$BCTX Can someone please remind me what the current/updated strike price is for the BCTXZ warrants? Thank you
2 replies
BCTX20bMC Nov 5, 5:49 PM
$BCTX now that tech is selling off…going to be a ton of cash looking for a new home. Patience…it will arrive here. 🌋
0 replies
SmallCapGrowth Nov 5, 5:30 PM
$BCTX: Award-winning, off-the-shelf immunotherapy platform aims to address key limitations of traditional cell therapies while expanding beyond breast cancer into new indications. Recognition, scalability, and multiple growth drivers are aligning. @biotech https://bit.ly/4Ad0M12
0 replies
SmallCapGrowth Nov 5, 5:08 PM
$BCTX just earned BioTech Breakthrough’s 2026 “Immunotherapy Solution of the Year” award for Bria-IMT™, further validating its novel approach to metastatic breast cancer treatment. Pivotal Phase 3 study underway, momentum builds #Biotech #CancerCare NEWS: https://bit.ly/4Ad0M12
0 replies
SmallCapGrowth Nov 5, 4:27 PM
Daily Hot Plays : $BCTX: Award-winning, off-the-shelf immu... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=178108545 via @Investors_Hub
0 replies
SmallCapGrowth Nov 5, 4:03 PM
🧬 Innovation in Focus! $BCTX is making headlines! BriaCell's Bria-IMT immunotherapy has been recognized as the 2026 Immunotherapy Solution of the Year. NEWS: https://bit.ly/4Ad0M12 #BCTX #Immunotherapy #Healthcare
0 replies
SmallCapGrowth Nov 5, 3:40 PM
$BCTX’s Bria-IMT™ named 2026 Immunotherapy Solution of the Year demonstrating median survival of 13.3-16.6 months in Phase 2 studies versus historical benchmarks of 5.9-9.8 months. Clinical validation + Phase 3 catalyst = one to watch. #Biotech NEWS: https://bit.ly/4Ad0M12
0 replies